Your browser doesn't support javascript.
loading
Successful treatment of a disseminated infection with extensively drug-resistant Klebsiella pneumoniae in a liver transplant recipient with a fosfomycin-based multidrug regimen.
Mills, J P; Wilck, M B; Weikert, B C; Porrett, P M; Timko, D; Alby, K; Bonomo, R A; Blumberg, E A.
Afiliação
  • Mills JP; Division of Infectious Diseases, Department of Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA. millsjo@umich.edu.
  • Wilck MB; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Weikert BC; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Porrett PM; Division of Transplant Surgery, Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Timko D; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Alby K; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Bonomo RA; Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Research Service, Cleveland, Ohio, USA.
  • Blumberg EA; Departments of Medicine, Pharmacology, and Molecular Biology and Microbiology, Case Western Reserve University, Cleveland, Ohio, USA.
Transpl Infect Dis ; 18(5): 777-781, 2016 Oct.
Article em En | MEDLINE | ID: mdl-27458980
ABSTRACT
Donor-derived infections with multidrug-resistant gram-negative bacteria are associated with poor outcomes, in part because of limited treatment options. Here, we describe a case of donor-derived, disseminated infection with colistin-resistant, carbapenemase-producing Klebsiella pneumoniae in a liver transplant recipient that was cured with addition of intravenous fosfomycin to a multidrug regimen, in conjunction with aggressive surgical source control. Intravenous fosfomycin represents a promising adjunctive agent for use in treatment of extensively drug-resistant infections in immunocompromised hosts.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose / Infecções por Klebsiella / Transplante de Fígado / Farmacorresistência Bacteriana Múltipla / Aloenxertos / Klebsiella pneumoniae / Antibacterianos Tipo de estudo: Etiology_studies Limite: Aged / Female / Humans Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrose / Infecções por Klebsiella / Transplante de Fígado / Farmacorresistência Bacteriana Múltipla / Aloenxertos / Klebsiella pneumoniae / Antibacterianos Tipo de estudo: Etiology_studies Limite: Aged / Female / Humans Idioma: En Revista: Transpl Infect Dis Assunto da revista: TRANSPLANTE Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos